| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/15/2008 | CN101285063A Novel conus P-superfamily toxin, sequence and uses thereof |
| 10/15/2008 | CN101284874A Peptide-based immunization therapy for treatment of atherosclerosis |
| 10/15/2008 | CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same |
| 10/15/2008 | CN101284858A Panaxadiol saponin microbial conversion products and method for preparing same |
| 10/15/2008 | CN101284855A Preparation method and use of camellin A and camellin B |
| 10/15/2008 | CN101284828A Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds |
| 10/15/2008 | CN101284810A Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates |
| 10/15/2008 | CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1 |
| 10/15/2008 | CN101284105A Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease |
| 10/15/2008 | CN101284093A Chinese herb medicine for treating coronary heart disease |
| 10/15/2008 | CN101284078A Nicandra physalodes (simple recipe) decocted in water for curing cardiovascular disease |
| 10/15/2008 | CN101284060A Antihypertensive pillow and preparation method thereof |
| 10/15/2008 | CN101284050A Corydalis tuber water soluble part medicament and its preparation method and application |
| 10/15/2008 | CN101284046A Thrombus clear health soft capsules |
| 10/15/2008 | CN101284037A Gadol extract and preparation method thereof |
| 10/15/2008 | CN101284035A Xuesaitong orally-administered freeze-dried tablets and preparation method thereof |
| 10/15/2008 | CN101284033A Chinese medicinal composition containing Fructus choerospondiatis and its preparation method and application |
| 10/15/2008 | CN101284030A Quality control methods of hairy holly root medicinal materials, extract or hairy holly root preparation |
| 10/15/2008 | CN101284028A Preparation method of nanometer granule of lignin active substance for cardiovascular medicaments |
| 10/15/2008 | CN101284013A Application of polysaccharide sulphate in preparing the medicine for improving the heart function |
| 10/15/2008 | CN101284012A Medicine composition for curing cardiovascular and cerebrovascular diseases |
| 10/15/2008 | CN101284003A Medicinal composition containing andrographolide derivatives and preparation method thereof and application |
| 10/15/2008 | CN101283997A Application of bromine phenolic compound in preparing the medicine for curing the ischemic cardio-vascular and cerebrovascular diseases |
| 10/15/2008 | CN101283995A Different pharmaceutical uses alpha2delta ligands |
| 10/15/2008 | CN101283994A Application of plumbagin in preparing the medicine for preventing the blood vessel from regenerating |
| 10/15/2008 | CN101283992A Trimetazidine hydrochloride dispersible tablet and preparation method thereof |
| 10/15/2008 | CN101283980A Propylgallate and sodium chloride injection |
| 10/15/2008 | CN101283799A Preparation method of health food for adjusting the blood fat |
| 10/15/2008 | CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 10/15/2008 | CN100425603C Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use |
| 10/15/2008 | CN100425592C Indole derivatives |
| 10/15/2008 | CN100425278C Chinese traditional medicine for curing diseases of cerebral hemorrhage, cerebral infarction and related sequela and its preparation method |
| 10/15/2008 | CN100425261C Chongcao Emiao oil capsules and preparation thereof |
| 10/15/2008 | CN100425256C Medicine for treating ischemic cexebral apoplexia and its prepn. method |
| 10/15/2008 | CN100425242C Erigeron breviscapus effervescent dry mixed suspension and its making method |
| 10/15/2008 | CN100425239C Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 10/15/2008 | CN100425233C Nimodipine gel for nasal cavity |
| 10/15/2008 | CN100425231C Oral formulation of danshensu and safflower yellow and preparation process thereof |
| 10/14/2008 | US7435756 Preparation and diabetic use of gibberellins |
| 10/14/2008 | US7435745 Methods and compositions for inhibition of angiogenesis |
| 10/14/2008 | US7435744 Brain disorders; central nervous system disorders; viricides |
| 10/14/2008 | US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 10/14/2008 | US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester |
| 10/14/2008 | US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/14/2008 | US7435729 using estrogen antagonist ; anticancer agents |
| 10/14/2008 | US7435725 Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 10/14/2008 | CA2497345C Novel quaternary ammonium compounds |
| 10/14/2008 | CA2445145C Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
| 10/14/2008 | CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 10/14/2008 | CA2382880C N-cyclopentyl modulators of chemokine receptor activity |
| 10/14/2008 | CA2339244C Methods of ophthalmic administration |
| 10/14/2008 | CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 10/14/2008 | CA2331395C Fatty acid analogues for the treatment of diabetes |
| 10/14/2008 | CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/14/2008 | CA2267449C Myocardial graft constructs |
| 10/14/2008 | CA2190394C Recombinant viruses, preparation and use thereof in gene therapy |
| 10/14/2008 | CA2185999C Treatment of congestive heart failure |
| 10/09/2008 | WO2008121859A1 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions |
| 10/09/2008 | WO2008121044A1 Ischemic disorder or disease inhibitors |
| 10/09/2008 | WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 10/09/2008 | WO2008120797A1 Ampk activator |
| 10/09/2008 | WO2008120778A1 Composition for promoting ketone compound formation |
| 10/09/2008 | WO2008120741A1 Sustained release preparation of basic fibroblast growth factor |
| 10/09/2008 | WO2008120724A1 Medicinal solid-dispersion preparation |
| 10/09/2008 | WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 10/09/2008 | WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 10/09/2008 | WO2008120655A1 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i |
| 10/09/2008 | WO2008120653A1 Indoledione derivative |
| 10/09/2008 | WO2008120085A2 Angiogenic composition |
| 10/09/2008 | WO2008119988A1 New combination for use in the treatment of inflammatory disorders |
| 10/09/2008 | WO2008119950A1 Porphyrin compounds |
| 10/09/2008 | WO2008119772A1 Amide derivatives as inhibitors of aspartyl proteases |
| 10/09/2008 | WO2008119744A1 Heterocyclic spiro-compounds |
| 10/09/2008 | WO2008119694A1 Benzimidazole cannabinoid agonists |
| 10/09/2008 | WO2008119500A1 Methods for treating neovascular ocular diseases |
| 10/09/2008 | WO2008119458A1 Substituted dibenzoic acid derivatives and use thereof |
| 10/09/2008 | WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof |
| 10/09/2008 | WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof |
| 10/09/2008 | WO2008086188A3 Thiophene carboxamides as factor xa inhibitors |
| 10/09/2008 | WO2008074679A3 4-imidazolines as taar's ligands |
| 10/09/2008 | WO2008064916A3 Agent for treating vascular leaks |
| 10/09/2008 | WO2008032105A3 Flavonoid derivatives and their uses |
| 10/09/2008 | WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 10/09/2008 | US20080249633 Biodegradable Materials and Methods of Use |
| 10/09/2008 | US20080249320 Luminacin analogs and uses thereof |
| 10/09/2008 | US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids |
| 10/09/2008 | US20080249176 Methods and Compositions for the Treatment of Myocardial Conditions |
| 10/09/2008 | US20080249174 A transgenic knockout animal whose genome comprises a heterozygous disruption of at least one endogenous gene, Sptlc1 and/or Sptlc2, encoding a serine palmitoyl-CoA transferase (SPT) subunit;screening SPT enzyme inhibitors for a ligand/protein binding Sptlc1 and/or Sptlc2; myriocin, antiatherosclerois |
| 10/09/2008 | US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids |
| 10/09/2008 | US20080249156 Combinations of statins and anti-obesity agent and glitazones |
| 10/09/2008 | US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates |
| 10/09/2008 | US20080249147 Emulsion-Stabilized Preparation |
| 10/09/2008 | US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder |
| 10/09/2008 | US20080249105 And Erectile Dysfunction; rho kinase inhibitors; [3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]amine |
| 10/09/2008 | US20080249100 N-[2-(2-{[(3,4-dichlorophenyl)methyl]amino}-7-oxo-8-hydropteridin-8-yl)ethyl]carboxamides; antidiabetic, anticholesterol, anticarcinogenic, antiischemic, hypotensive agents; obesity, stroke |
| 10/09/2008 | US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249087 Heterocylic antiviral compounds |
| 10/09/2008 | US20080249086 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction; arrhythmia |
| 10/09/2008 | US20080249072 Use of Low Dose Chemically Modified Tetracylines to Reduce Inflammatory Mediators |